Adjuvant Paclitaxel/Gemcitabine/Cisplatin Improves Survival in Patients With Resected Locally Invasive Bladder Cancer
Capsule Summary - Compared with observation, adjuvant PGC significantly improved all efficacy outcomes, including OS, in patients with resected invasive transitional cell carcinoma of the bladder.
Source: Clinical Care Options Oncology - Prostate Cancer - Category: Cancer & Oncology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Prostate Cancer | Transitional Cell Carcinoma